Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP294954.RAje_pssODGkPufouy_hqp3yd45cx_aq2Hx6IjZy_U80k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP294954.RAje_pssODGkPufouy_hqp3yd45cx_aq2Hx6IjZy_U80k130_assertion type Assertion NP294954.RAje_pssODGkPufouy_hqp3yd45cx_aq2Hx6IjZy_U80k130_head.
- NP294954.RAje_pssODGkPufouy_hqp3yd45cx_aq2Hx6IjZy_U80k130_assertion description "[The median normalized BCR-ABL transcript level was measured as 0.004% in 17 patients with a molecular relapse, 0.4% in 7 patients with a cytogenetic relapse, 2.6% in 36 patients with a stable phase of CML, and 36% in 5 patients with a relapse in a blast crisis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294954.RAje_pssODGkPufouy_hqp3yd45cx_aq2Hx6IjZy_U80k130_provenance.
- NP294954.RAje_pssODGkPufouy_hqp3yd45cx_aq2Hx6IjZy_U80k130_assertion evidence source_evidence_literature NP294954.RAje_pssODGkPufouy_hqp3yd45cx_aq2Hx6IjZy_U80k130_provenance.
- NP294954.RAje_pssODGkPufouy_hqp3yd45cx_aq2Hx6IjZy_U80k130_assertion SIO_000772 10985361 NP294954.RAje_pssODGkPufouy_hqp3yd45cx_aq2Hx6IjZy_U80k130_provenance.
- NP294954.RAje_pssODGkPufouy_hqp3yd45cx_aq2Hx6IjZy_U80k130_assertion wasDerivedFrom befree-2016 NP294954.RAje_pssODGkPufouy_hqp3yd45cx_aq2Hx6IjZy_U80k130_provenance.
- NP294954.RAje_pssODGkPufouy_hqp3yd45cx_aq2Hx6IjZy_U80k130_assertion wasGeneratedBy ECO_0000203 NP294954.RAje_pssODGkPufouy_hqp3yd45cx_aq2Hx6IjZy_U80k130_provenance.